Lancet, J., Ravandi, F., Ricklis, R., Cripe, L., Kantarjian, H., Giles, F., . . . Karp, J. (2011). A phase Ib study of vosaroxin, an anticancer quinolone derivative, in patients with relapsed or refractory acute leukemia. Leukemia.
Citação norma ChicagoLancet, JE, et al. "A Phase Ib Study of Vosaroxin, an Anticancer Quinolone Derivative, in Patients With Relapsed or Refractory Acute Leukemia." Leukemia 2011.
Citação norma MLALancet, JE, et al. "A Phase Ib Study of Vosaroxin, an Anticancer Quinolone Derivative, in Patients With Relapsed or Refractory Acute Leukemia." Leukemia 2011.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.